Premium
Administration of recombinant adeno‐associated virus vector to the diaphragm through direct intramuscular injection
Author(s) -
Smuder Ashley J,
Falk Darin J,
Nelson W Bradley,
Powers Scott K
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.1075.21
Subject(s) - diaphragm (acoustics) , electroporation , genetic enhancement , recombinant dna , transfection , adeno associated virus , duchenne muscular dystrophy , medicine , gene delivery , intramuscular injection , microbiology and biotechnology , muscular dystrophy , vector (molecular biology) , pharmacology , biology , gene , genetics , physics , acoustics , loudspeaker
Ventilatory insufficiency due to impaired diaphragm function is the leading cause of morbidity and mortality in many conditions (e.g. muscular dystrophy). Currently, pharmacological inhibitors and genetically modified animals are used to study many diseases affecting the diaphragm. However, these methodologies are problematic due to the occurrence of off‐target effects and possible consequences of life‐long genetic alterations. Further, conventional approaches to gene transfection (i.e., plasmid injection and electroporation) are not possible due to the size and location of the diaphragm and thus alternative methods are needed to alter gene expression. Therefore, we have developed a method for the delivery of recombinant adeno‐associated virus vectors (rAAV) to the rat diaphragm via direct intramuscular injection. We hypothesized that by directly injecting rAAV we could selectively target diaphragm muscle fibers and establish a novel animal model for studying signaling pathways and also provide a strategy for effectively using gene therapy to rescue the diaphragm in disease states. Our results demonstrate that the morphology of the rat diaphragm is sufficient to allow direct injection and provide support for the use of rAAV as an intervention to study the diaphragm during conditions that promote diaphragm dysfunction. Supported by NIH RO1 HL087839 to SKP, T32 HD043730 to AJS and F32 HL095282 to DJF